Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Clin Trials. 2015 Nov 4;13(3):331–337. doi: 10.1177/1740774515615540

Table 2.

Agreement between patients and clinicians in their toxicity and performance status ratings at cycle 3 of treatment, comparing shared reporting (patient reports shared with clinicians at point of care) versus non-shared reporting (patient reports not shared with clinicians).

Weighted kappa values
Shared reporting Non-shared reporting p value
Pain 0.82 0.39   0.001
Nausea 0.91 0.48 <0.001
Fatigue 0.84 0.04 <0.001
Dyspnea 0.91 0.38 <0.001
Cough 0.92 0.36   0.002
Anorexia 0.9 0.21 <0.001
KPS 0.83 0.24 <0.001

KPS: Karnofsky Performance Status.